GlassScriptPhysician profile
Sonya F C Johnson
NPI 1831169036
$10,108.33
in general payments reported to CMS, 2019-2025
41 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $886 · 2021: $470 · 2022: $2,625 · 2023: $1,565 · 2024: $1,675 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,585 · Education: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,585.25 |
| Education | $409.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,347.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,183.32 | 2019-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $967.09 | 2019-2025 | Tremfya |
| Abbvie INC. | $889.58 | 2019-2025 | Rinvoq |
| Pfizer INC. | $624.69 | 2019-2025 | |
| Galderma Laboratories, L.P. | $552.32 | 2020-2025 | Nemluvio, Aklief |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $497.94 | 2019-2024 | Cabtreo |
| Sun Pharmaceutical Industries INC. | $396.09 | 2021-2025 | Winlevi, Absorica Ld |
| Dermavant Sciences, INC. | $382.17 | 2023-2024 | Vtama |
| Lilly USA, LLC | $313.25 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Arcutis Biotherapeutics, INC. | $218.19 | 2023-2025 | Zoryve |
| Ucb, INC. | $178.89 | 2020-2025 | Bimzelx |
| Incyte Corporation | $163.16 | 2022-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $143.49 | 2019-2020 | |
| Journey Medical Corporation | $120.30 | 2022-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $111.94 | 2020-2021 | |
| Merz North America, INC. | $111.84 | 2022-2024 | Xeomin |
| E.R. Squibb & Sons, L.L.C. | $109.06 | 2022-2025 | Sotyktu |
| Genentech USA, INC. | $100.77 | 2019-2024 | Erivedge |
| Smith+Nephew, INC. | $79.00 | 2023-2024 | Collagenase Santyl |
| Amgen INC. | $78.31 | 2023-2024 | Otezla |
| Leo Pharma INC. | $78.26 | 2020-2025 | Adbry |
| Encore Dermatology INC. | $44.51 | 2019-2020 | |
| Organon LLC | $41.37 | 2025 | Vtama |
| Kyowa Kirin, INC. | $38.94 | 2022-2023 | Poteligeo |
| Janssen Scientific Affairs, LLC | $36.01 | 2021-2023 | Tremfya |
| Genzyme Corporation | $29.30 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.07 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $26.97 | 2019 | |
| Merck Sharp & Dohme LLC | $26.42 | 2019 | |
| Triad Life Sciences INC. | $26.10 | 2022 | |
| Polynovo North America LLC | $23.08 | 2024 | Novosorb Btm |
| Lnhc, INC | $20.29 | 2025 | Zelsuvmi |
| Prugen, INC. Pharmaceuticals | $17.34 | 2019 | |
| Almirall LLC | $16.36 | 2019 | |
| Botanix Sb INC | $15.62 | 2025 | Sofdra |
| Medline Industries LP | $14.71 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.20 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $14.10 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Surgenex LLC | $13.77 | 2025 | Pellograft, Ardeograft, Surgraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.